DH Stock Price, Definitive Healthcare . Quote, Chart

Market Summary

USD5.49-0.01

Delayed

-0.18%

DH Alerts

Big jump in Earnings (Y/Y)

Losses in recent quarter

DH Stock Price

View Fullscreen

DH RSI Chart

DH Valuation

Market Cap

647.5M

Price/Earnings (Trailing)

-3.25

Price/Sales (Trailing)

2.53

EV/EBITDA

-3.11

Price/Free Cashflow

15.82

DH Price/Sales (Trailing)

DH Profitability

EBT Margin

-119.28%

Return on Equity

-16.69%

Return on Assets

-11.02%

Free Cashflow Yield

6.32%

DH Fundamentals

DH Revenue

Revenue (TTM)

255.7M

Rev. Growth (Yr)

7.23%

Rev. Growth (Qtr)

-3.72%

DH Earnings

Earnings (TTM)

-199.4M

Earnings Growth (Yr)

40.41%

Earnings Growth (Qtr)

-40.82%

Breaking Down DH Revenue

Last 7 days

3.2%

Last 30 days

-23.6%

Last 90 days

-45.1%

Trailing 12 Months

-40.1%

How does DH drawdown profile look like?

DH Financial Health

Current Ratio

2.3

Debt/Equity

0.2

Debt/Cashflow

0.18

DH Investor Care

Shares Dilution (1Y)

7.00%

Diluted EPS (TTM)

-1.75

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	255.7M	0	0	0
2023	231.7M	238.1M	246.1M	251.4M
2022	179.3M	194.1M	208.4M	222.7M
2021	128.9M	140.5M	153.5M	166.2M
2020	0	0	0	118.3M
2019	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Definitive Healthcare Corp.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 03, 2024	maack jonathan	sold (taxes)	-70,447	7.03	-10,021	president
May 01, 2024	krantz jason ronald	sold (taxes)	-53,376	6.97	-7,658	interim ceo
May 01, 2024	moschella william	acquired	-	-	297,686	chief product & tech officer
May 01, 2024	shamsuddin kate marie	sold (taxes)	-17,466	6.97	-2,506	chief strategy officer
May 01, 2024	booth richard douglas	sold (taxes)	-25,231	6.97	-3,620	chief financial officer
Mar 14, 2024	booth richard douglas	sold (taxes)	-8,033	8.09	-993	chief financial officer
Mar 14, 2024	krantz jason ronald	sold (taxes)	-22,716	8.09	-2,808	interim ceo
Mar 14, 2024	shamsuddin kate marie	sold (taxes)	-8,445	8.09	-1,044	chief product officer
Feb 16, 2024	krantz jason ronald	sold (taxes)	-54,135	9.99	-5,419	interim ceo
Feb 14, 2024	maack jonathan	acquired	-	-	214,995	president

Which funds bought or sold DH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	added	9.27	-448,659	3,525,230	0.01%
May 16, 2024	JANE STREET GROUP, LLC	reduced	-44.87	-162,047	131,282	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-2.17	-108,372	418,438	-%
May 15, 2024	ArrowMark Colorado Holdings LLC	reduced	-26.31	-5,713,380	8,509,780	0.10%
May 15, 2024	Granahan Investment Management, LLC	sold off	-100	-7,294,000	-	-%
May 15, 2024	BAMCO INC /NY/	unchanged	-	-6,529,050	28,176,200	0.07%
May 15, 2024	Royal Bank of Canada	added	3.51	-427,000	2,255,000	-%
May 15, 2024	STEPHENS INC /AR/	added	30.5	7,267	129,330	-%
May 15, 2024	Point72 Asset Management, L.P.	new	-	6,573,820	6,573,820	0.02%
May 15, 2024	PALISADE CAPITAL MANAGEMENT, LP	added	20.27	-257,792	10,700,200	0.28%

Are Funds Buying or Selling DH?

Are funds buying DH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own DH

No. of Funds

Unveiling Definitive Healthcare Corp.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	advent international, l.p.	53.7%	62,493,676	SC 13G/A
Feb 13, 2024	krantz jason ronald	15.8%	21,787,263	SC 13G/A
Feb 09, 2024	sea vii management, llc	10.6%	13,811,367	SC 13G/A
Feb 08, 2024	echo street capital management llc	0%	0	SC 13G/A
Jan 05, 2024	conestoga capital advisors, llc	5.01%	5,824,812	SC 13G
Feb 14, 2023	echo street capital management llc	5.5%	5,751,074	SC 13G
Feb 14, 2023	sea vii management, llc	17.4%	22,124,496	SC 13G/A
Feb 13, 2023	krantz jason ronald	16.97%	21,387,853	SC 13G/A
Feb 14, 2022	advent international corp/ma	64.4%	62,493,676	SC 13G
Feb 14, 2022	sea vii management, llc	21.2%	26,747,318	SC 13G

Recent SEC filings of Definitive Healthcare Corp.

View All Filings

Date Filed	Form Type	Document
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	4	Insider Trading
May 07, 2024	8-K	Current Report
May 07, 2024	DEFA14A	DEFA14A
May 03, 2024	3	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
Apr 09, 2024	ARS	ARS

Peers (Alternatives to Definitive Healthcare Corp.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Definitive Healthcare Corp. News

Latest updates

Definitive Healthcare Corp. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q2
Revenue	-3.7%	63.00	66.00	65.00	61.00	59.00	61.00	57.00	55.00	50.00	46.00	43.00	40.00	37.00	34.00	30.00	28.00	26.00	-	-
Gross Profit	-5.7%	50.00	53.00	53.00	50.00	47.00	51.00	48.00	43.00	39.00	35.00	33.00	30.00	27.00	25.00	23.00	21.00	19.00	-	-
Operating Expenses	4.9%	67.00	63.00	349	62.00	60.00	61.00	58.00	55.00	50.00	49.00	37.00	37.00	30.00	33.00	24.00	23.00	24.00	-	-
S&GA Expenses	-7.8%	22.00	24.00	23.00	25.00	23.00	24.00	21.00	24.00	21.00	17.00	14.00	13.00	12.00	11.00	8.00	8.00	8.00	-	-
R&D Expenses	-12.4%	10.00	12.00	11.00	10.00	10.00	10.00	9.00	9.00	7.00	6.00	5.00	4.00	4.00	3.00	3.00	2.00	2.00	-	-
EBITDA Margin	2.9%	-0.98*	-1.01*	-1.04*	0.01*	0.02*	0.03*	0.02*	-0.04*	-0.04*	0.01*	0.05*	0.15*	-	-	-	-	-	-	-
Interest Expenses	-2.1%	4.00	4.00	4.00	4.00	4.00	1.00	3.00	3.00	2.00	2.00	7.00	8.00	8.00	9.00	9.00	9.00	9.00	-	-
Income Taxes	-166.4%	-0.78	1.00	-17.53	-1.48	-0.71	-17.04	-0.01	-0.21	-0.43	0.00	-0.21	-0.24	-0.24	-	-	-	-	-	-
Earnings Before Taxes	-10.8%	-13.50	-12.19	-266	-13.09	-16.68	-11.16	-6.90	-10.35	-13.46	-14.86	-21.58	-15.37	-10.95	-16.36	-10.26	-11.82	-14.16	-	-
EBT Margin	2.7%	-1.19*	-1.23*	-1.25*	-0.20*	-0.19*	-0.19*	-0.22*	-0.31*	-0.36*	-0.38*	-0.42*	-0.38*	-	-	-	-	-	-	-
Net Income	-40.8%	-9.52	-6.76	-171	-11.60	-15.97	10.00	-3.02	-10.14	-13.04	-9.86	-7.98	-	-	-	-	-	-	-	-
Net Income Margin	4.8%	-0.78*	-0.82*	-0.77*	-0.09*	-0.08*	-0.07*	-0.17*	-0.21*	-0.17*	-0.11*	-0.05*	-	-	-	-	-	-	-	-
Free Cashflow	296.7%	16.00	4.00	9.00	11.00	14.00	-9.09	9.00	15.00	13.00	3.00	-1.28	8.00	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																			(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2018Q4
Assets	-0.9%	1,810	1,826	1,820	2,105	2,117	2,123	2,121	2,124	2,143	2,118	1,871	1,731	1,739	1,747	1,741	1,734	1,728	1,721	-
Current Assets	-3.9%	379	394	375	421	421	414	402	396	392	444	227	-	-	64.00	-	-	-	36.00	35.00
Cash Equivalents	-19.1%	106	131	77.00	132	125	147	229	228	230	387	190	38.00	33.00	25.00	35.00	-	-	9.00	19.00
Net PPE	-8.3%	4.00	4.00	5.00	4.00	4.00	4.00	5.00	5.00	5.00	5.00	5.00	-	-	3.00	-	-	-	3.00	-
Goodwill	0.7%	1,082	1,075	1,074	1,325	1,325	1,325	1,325	1,325	1,325	1,263	1,263	1,263	1,263	1,263	-	-	-	1,233	19.00
Liabilities	-1.9%	615	627	616	649	653	641	648	640	649	618	591	560	557	554	542	530	517	505	37.00
Current Liabilities	-3.3%	165	171	147	148	151	141	129	126	128	123	107	102	95.00	91.00	85.00	97.00	98.00	70.00	37.00
Long Term Debt	-1.4%	239	243	246	249	252	256	259	261	262	264	265	-	-	457	-	-	-	435	-
LT Debt, Current	0%	14.00	14.00	14.00	12.00	10.00	9.00	7.00	7.00	7.00	7.00	7.00	-	-	5.00	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	243	246	249	252	256	259	261	262	264	265	-	-	457	-	-	-	435	-
Shareholder's Equity	-0.3%	1,195	1,199	1,203	1,455	1,464	1,482	1,473	1,484	1,494	1,500	1,280	1,171	1,182	1,193	1,178	1,190	1,201	1,216	-
Retained Earnings	-4.2%	-236	-227	-217	-45.69	-37.12	-25.06	-34.93	-31.91	-26.42	-17.84	-7.80	-	-	-109	-	-	-	-55.76	-
Additional Paid-In Capital	0.8%	1,095	1,087	1,077	1,051	1,019	970	961	928	898	889	699	-	-	-	-	-	-	-	-
Shares Outstanding	4.1%	117	113	115	-	108	101	100	98.00	97.00	92.00	88.00	-	-	128	-	-	-	-	-
Minority Interest	-0.9%	335	338	340	447	479	533	543	587	622	629	589	-	-	-	-	-	-	-	-
Float	-	-	-	-	526	-	-	-	811	-	-	-	866	-	-	-	-	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q2
Cashflow From Operations	252.3%	16,589	4,709	9,487	12,037	14,957	-4,220	10,685	15,481	13,633	4,219	-948	8,414	13,527	8,673	-	-	-	-	-
Share Based Compensation	17.6%	15,582	13,254	11,994	12,363	11,128	11,424	9,133	9,005	6,872	5,619	2,317	1,615	406	417	-	-	-	-	-
Cashflow From Investing	-144.2%	-24,034	54,407	-54,059	1,340	-33,470	-67,886	-3,984	-10,181	-166,852	-41,069	-440	-1,380	-3,842	-15,866	-	-	-	-	-
Cashflow From Financing	-183.6%	-17,194	-6,062	-10,366	-5,631	-3,525	-9,457	-6,115	-6,748	-4,376	234,677	152,757	-1,766	-1,296	-2,861	-	-	-	-	-
Buy Backs	-	-	-	-	-	-	-	-	-	-	138,960	-63,209	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

DH Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 63,480	$ 59,201
Cost of revenue:
Cost of revenue exclusive of amortization	9,736	8,552
Amortization	3,362	3,354
Gross profit	50,382	47,295
Operating expenses:
Sales and marketing	21,760	23,423
Product development	10,132	9,884
General and administrative	16,883	14,079
Depreciation and amortization	9,322	9,590
Transaction, integration and restructuring expenses	8,534	2,590
Total operating expenses	66,631	59,566
Loss from operations	(16,249)	(12,271)
Other income (expense), net:
Interest income	3,927	2,834
Interest expense	(3,816)	(3,614)
Gain (loss) on remeasurement of TRA liability	2,267	(3,552)
Other income (expense), net	373	(79)
Total other income (expense), net	2,751	(4,411)
Net loss before income taxes	(13,498)	(16,682)
Benefit from income taxes	780	710
Net loss	(12,718)	(15,972)
Less: Net loss attributable to noncontrolling interests	(3,200)	(3,909)
Net loss attributable to Definitive Healthcare Corp.	$ (9,518)	$ (12,063)
Net loss per share of Class A common stock:
Basic	$ (0.08)	$ (0.11)
Diluted	$ (0.08)	$ (0.11)
Weighted average Class A Common Stock outstanding:
Basic	117,433,520	108,234,043
Diluted	117,433,520	108,234,043

DH Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 105,994	$ 130,976
Short-term investments	189,174	177,092
Accounts receivable, net	56,655	59,249
Prepaid expenses and other current assets	13,296	13,120
Deferred contract costs	13,598	13,490
Total current assets	378,717	393,927
Property and equipment, net	4,100	4,471
Operating lease right-of-use assets, net	9,022	9,594
Other assets	1,978	2,388
Deferred contract costs	16,219	17,320
Intangible assets, net	317,972	323,121
Goodwill	1,082,137	1,075,080
Total assets	1,810,145	1,825,901
Current liabilities:
Accounts payable	4,895	5,787
Accrued expenses and other liabilities	35,950	51,529
Deferred revenue	108,078	97,377
Term loan	13,750	13,750
Operating lease liabilities	2,307	2,239
Total current liabilities	164,980	170,682
Long term liabilities:
Deferred revenue	9	9
Term loan	239,267	242,567
Operating lease liabilities	8,690	9,372
Tax receivable agreements liability	125,150	127,000
Deferred tax liabilities	66,615	67,163
Other liabilities	10,403	9,934
Total liabilities	615,114	626,727
Equity:
Additional paid-in capital	1,095,482	1,086,581
Accumulated other comprehensive income	1,658	2,109
Accumulated deficit	(236,968)	(227,450)
Noncontrolling interests	334,741	337,817
Total equity	1,195,031	1,199,174
Total liabilities and equity	1,810,145	1,825,901
Common Class A
Equity:
Common stock, value	118	117
Common Class B
Equity:
Common stock, value	$ 0	$ 0

About Definitive Healthcare Corp.

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

CEO	Mr. Robert W. Musslewhite J.D.
WEBSITE	definitivehc.com
INDUSTRY	Healthcare Plans
EMPLOYEES	946

Definitive Healthcare Corp. Frequently Asked Questions

What is the ticker symbol for Definitive Healthcare Corp.? What does DH stand for in stocks?

DH is the stock ticker symbol of Definitive Healthcare Corp.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Definitive Healthcare Corp. (DH)?

As of Fri May 17 2024, market cap of Definitive Healthcare Corp. is 647.46 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DH stock?

You can check DH's fair value in chart for subscribers.

What is the fair value of DH stock?

You can check DH's fair value in chart for subscribers. The fair value of Definitive Healthcare Corp. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Definitive Healthcare Corp. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Definitive Healthcare Corp. a good stock to buy?

The fair value guage provides a quick view whether DH is over valued or under valued. Whether Definitive Healthcare Corp. is cheap or expensive depends on the assumptions which impact Definitive Healthcare Corp.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DH.

What is Definitive Healthcare Corp.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, DH's PE ratio (Price to Earnings) is -3.25 and Price to Sales (PS) ratio is 2.53. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DH PE ratio will change depending on the future growth rate expectations of investors.